Richard Vosser

Stock Analyst at JP Morgan

(1.46)

# 3,216

Out of 4,784 analysts

10

Total ratings

57.14%

Success rate

-1.81%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Richard Vosser

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MOLN Molecular Partners AG	Maintains: Neutral	$6.6 → $4.5	$4.56	-1.39%	1	Dec 5, 2023
	NVO Novo Nordisk	Upgrades: Overweight	n/a	$69.30	-	7	Jun 7, 2022
	SNY Sanofi	Upgrades: Overweight	n/a	$55.82	-	2	Jan 6, 2020

Molecular Partners AG

Dec 5, 2023

Maintains: Neutral

Price Target: $6.6 → $4.5

Current: $4.56

Upside: -1.39%

Novo Nordisk

Jun 7, 2022

Upgrades: Overweight

Price Target: n/a

Current: $69.30

Upside: -

Sanofi

Jan 6, 2020

Upgrades: Overweight

Price Target: n/a

Current: $55.82

Upside: -